Definitive treatment of Graves' disease in children and adolescents.

Król, Aleksandra; Czarniecka, Agnieszka; Jarzab, Barbara

Król, Aleksandra; Czarniecka, Agnieszka; Jarzab, Barbara.

Affiliation

Król A; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland. aleksandra.krol@io.gliwice.pl.
Czarniecka A; The Oncologic and Reconstructive Surgery Clinic, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Jarzab B; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.

Endokrynol Pol ; 72(6): 661-665, 2021.

Article in En | MEDLINE | ID: mdl-34855196

Subject(s)

Antithyroid Agents/therapeutic use; Graves Disease/therapy; Iodine Radioisotopes/therapeutic use; Thyroidectomy; Adolescent; Antithyroid Agents/adverse effects; Child; Graves Disease/drug therapy; Humans; Thyroid Neoplasms; Treatment Outcome

Key words

Graves' disease (GD); antithyroid drugs (ATDs); radioactive iodine (RAI); total thyroidectomy (TT)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antithyroid Agents / Thyroidectomy / Graves Disease / Iodine Radioisotopes Type of study: Guideline / Risk_factors_studies Limits: Adolescent / Child / Humans Language: En Journal: Endokrynol Pol Year: 2021 Document type: Article Affiliation country: Poland Country of publication: Poland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google